SUR1, newly expressed in astrocytes, mediates neuropathic pain in a mouse model of peripheral nerve injury
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Molecular Pain
- Vol. 17
Abstract
Neuropathic pain following peripheral nerve injury (PNI) is linked to neuroinflammation in the spinal cord marked by astrocyte activation and upregulation of interleukin 6 (IL-6), chemokine (C-C motif) ligand 2 (CCL2) and chemokine (C-X-C motif) ligand 1 (CXCL1), with inhibition of each individually being beneficial in pain models. Wild type (WT) mice and mice with global or pGfap-cre- or pGFAP-cre/ERT2-driven Abcc8/SUR1 deletion or global Trpm4 deletion underwent unilateral sciatic nerve cuffing. WT mice received prophylactic (starting on post-operative day [pod]-0) or therapeutic (starting on pod-21) administration of the SUR1 antagonist, glibenclamide (10 µg IP) daily. We measured mechanical and thermal sensitivity using von Frey filaments and an automated Hargreaves method. Spinal cord tissues were evaluated for SUR1-TRPM4, IL-6, CCL2 and CXCL1. Sciatic nerve cuffing in WT mice resulted in pain behaviors (mechanical allodynia, thermal hyperalgesia) and newly upregulated SUR1-TRPM4 in dorsal horn astrocytes. Global and pGfap-cre-driven Abcc8 deletion and global Trpm4 deletion prevented development of pain behaviors. In mice with Abcc8 deletion regulated by pGFAP-cre/ERT2, after pain behaviors were established, delayed silencing of Abcc8 by tamoxifen resulted in gradual improvement over the next 14 days. After PNI, leakage of the blood-spinal barrier allowed entry of glibenclamide into the affected dorsal horn. Daily repeated administration of glibenclamide, both prophylactically and after allodynia was established, prevented or reduced allodynia. The salutary effects of glibenclamide on pain behaviors correlated with reduced expression of IL-6, CCL2 and CXCL1 by dorsal horn astrocytes. SUR1-TRPM4 may represent a novel non-addicting target for neuropathic pain.Keywords
Funding Information
- U.S. Department of Veterans Affairs (I01RX003060)
- National Institute of Neurological Disorders and Stroke (R01NS105633, R01NS107262)
This publication has 71 references indexed in Scilit:
- The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) ChannelJournal of Biological Chemistry, 2013
- Sex differences in the contribution of ATP-sensitive K+ channels in trigeminal ganglia under an acute muscle pain conditionNeuroscience, 2011
- NeuPSIG guidelines on neuropathic pain assessmentPain, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- KATP Channel Subunits in Rat Dorsal Root Ganglia: Alterations by Painful AxotomyMolecular Pain, 2010
- Neuropathic Pain: A Maladaptive Response of the Nervous System to DamageAnnual Review of Neuroscience, 2009
- JNK-Induced MCP-1 Production in Spinal Cord Astrocytes Contributes to Central Sensitization and Neuropathic PainThe Journal of Neuroscience, 2009
- Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2008
- Species and strain differences in rodent sciatic nerve anatomy: Implications for studies of neuropathic painPain, 2008
- Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4Nature Immunology, 2007